Ann Dermatol.  2018 Jun;30(3):371-372. 10.5021/ad.2018.30.3.371.

Multiple Lentigines Arising in Sites of Resolving Psoriatic Plaques after Treatment with Ustekinumab

• Kim JS
• Lee SK
• Ryu HR
• Yun CH
• Baek JO
• Roh JY
• Lee JR

• KMID: 2419186
• DOI: http://doi.org/10.5021/ad.2018.30.3.371

Abstract

No abstract available.

MeSH Terms

Lentigo*
Ustekinumab*
Ustekinumab

Figure

• 

  Fig. 1 (A~C) Multiple lentigines confined to resolving psoriatic plaques and one of the lentigines (indicated by arrows) was biopsied.

• 

  Fig. 2 Photomicrograph showing basal layer hyperpigmentation (H&E, ×200).

Reference

1. Costa LA, Belinchón I, Betlloch I, Pérez-Crespo M, Mataix J. Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept. Dermatol Online J. 2008; 14:11.

2. Martí N, Molina I, López V, Terradez L, Jordá E. Multiple lentigines confined to a resolving psoriatic plaque. Dermatol Online J. 2009; 15:15.

3. Dogan S, Atakan N. Multiple lentigines confined to psoriatic plaques induced by biologic agents in psoriasis therapy: a case and review of the literature. Cutan Ocul Toxicol. 2015; 34:262–264.

4. Gutiérrez-González E, Batalla A, de la. Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy. Dermatol Online J. 2014; 20:22338.

5. Agusti-Mejias A, Messeguer F, García R, Febrer I. Severe refractory atopic dermatitis in an adolescent patient successfully treated with ustekinumab. Ann Dermatol. 2013; 25:368–370.